New Research Study Provides Further Evidence of Strong Correlation of TriPath Imaging's ProEx C Biomarkers with Biopsy Evidence
07 Novembro 2005 - 2:46PM
PR Newswire (US)
In-house and External Retrospective Research Studies Incorporating
ProEx C Biomarkers Presented at 53rd Annual Scientific Meeting of
the American Society of Cytopathology BURLINGTON, N.C., Nov. 7
/PRNewswire-FirstCall/ -- TriPath Imaging, Inc. (NASDAQ:TPTH) today
announced that the results of a new in-house retrospective research
study demonstrated that testing of cervical cytology specimens with
Research Use Only (RUO) reagents incorporating the Company's
proprietary ProEx C biomarkers yielded a 93% (p
Tripath Imaging (NASDAQ:TPTH)
Gráfico Histórico do Ativo
De Mai 2024 até Jun 2024
Tripath Imaging (NASDAQ:TPTH)
Gráfico Histórico do Ativo
De Jun 2023 até Jun 2024
Notícias em tempo-real sobre Tripath Imaging da NASDAQ bolsa de valores: 0 artigos recentes
Mais Notícias de Tripath Imaging Inc. (MM)